Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01654796 · ClinicalTrials.gov registry record · NA
Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT01654796: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01654796 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01654796, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study is looking at the safety and efficacy of low field magnetic stimulation (LFMS) for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.
Interventions
- DEVICE Low Field Magnetic Stimulation (LFMS)
- DEVICE Sham LFMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01654796
The ClinicalTrials.gov registry entry for NCT01654796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Field Magnetic Stimulation (LFMS) is the first listed.
NCT01654796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01654796 about?
NCT01654796 is a clinical study titled "Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression". This study is looking at the safety and efficacy of low field magnetic stimulation (LFMS) for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.
What is the current status of trial NCT01654796?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2013-04. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01654796?
The interventions under investigation include: Low Field Magnetic Stimulation (LFMS) (DEVICE), Sham LFMS (DEVICE).
Who is sponsoring clinical trial NCT01654796?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.